41 related articles for article (PubMed ID: 1352428)
1. Management of glaucoma in pregnancy: risks or choices, a dilemma?
Sethi HS; Naik M; Gupta VS
Int J Ophthalmol; 2016; 9(11):1684-1690. PubMed ID: 27990376
[TBL] [Abstract][Full Text] [Related]
2. Selective Laser Trabeculoplasty.
Wu CM; Chang TC
Int Ophthalmol Clin; 2023 Oct; 63(4):23-32. PubMed ID: 37755442
[TBL] [Abstract][Full Text] [Related]
3. Fixed High Energy Versus Standard Titrated Energy Settings for Selective Laser Trabeculoplasty.
N Murthy S; Goel P; Dubey S; Gandhi M
J Glaucoma; 2024 Mar; ():. PubMed ID: 38536120
[No Abstract] [Full Text] [Related]
4. Perioperative medications for preventing temporarily increased intraocular pressure after laser trabeculoplasty.
Zhang L; Weizer JS; Musch DC
Cochrane Database Syst Rev; 2017 Feb; 2(2):CD010746. PubMed ID: 28231380
[TBL] [Abstract][Full Text] [Related]
5. Effects of common topical antiglaucoma medications on the ocular surface, eyelids and periorbital tissue.
Servat JJ; Bernardino CR
Drugs Aging; 2011 Apr; 28(4):267-82. PubMed ID: 21428462
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological management of primary open-angle glaucoma: second-line options and beyond.
Webers CA; Beckers HJ; Nuijts RM; Schouten JS
Drugs Aging; 2008; 25(9):729-59. PubMed ID: 18729546
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological therapy for glaucoma: a review.
Hoyng PF; van Beek LM
Drugs; 2000 Mar; 59(3):411-34. PubMed ID: 10776828
[TBL] [Abstract][Full Text] [Related]
8. Long term effect of apraclonidine.
Araujo SV; Bond JB; Wilson RP; Moster MR; Schmidt CM; Spaeth GL
Br J Ophthalmol; 1995 Dec; 79(12):1098-101. PubMed ID: 8562543
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of action and efficacy of argon laser trabeculoplasty and selective laser trabeculoplasty.
Stein JD; Challa P
Curr Opin Ophthalmol; 2007 Mar; 18(2):140-5. PubMed ID: 17301616
[TBL] [Abstract][Full Text] [Related]
10. Questions concerning the role of apraclonidine in the management of glaucoma.
Robin AL
Arch Ophthalmol; 1995 Jun; 113(6):712-4. PubMed ID: 7786208
[No Abstract] [Full Text] [Related]
11. Apraclonidine and argon laser trabeculoplasty.
Holmwood PC; Chase RD; Krupin T; Rosenberg LF; Ruderman JM; Tallman BA; Brodstein DE; Chopra H; Goldenfeld M
Am J Ophthalmol; 1992 Jul; 114(1):19-22. PubMed ID: 1352428
[TBL] [Abstract][Full Text] [Related]
12. Chronic use of apraclonidine decreases its moderation of post-laser intraocular pressure spikes.
Chung HS; Shin DH; Birt CM; Kim C; Lee D; Levin DS; Hakimzadeh R; Juzych MS
Ophthalmology; 1997 Nov; 104(11):1921-5. PubMed ID: 9373127
[TBL] [Abstract][Full Text] [Related]
13. Apraclonidine and anterior segment laser surgery. Comparison of 0.5% versus 1.0% apraclonidine for prevention of postoperative intraocular pressure rise.
Rosenberg LF; Krupin T; Ruderman J; McDaniel DL; Siegfried C; Karalekas DP; Grewal RK; Gieser DK; Williams R
Ophthalmology; 1995 Sep; 102(9):1312-8. PubMed ID: 9097768
[TBL] [Abstract][Full Text] [Related]
14. Early intraocular pressure response to laser trabeculoplasty 180 degrees without apraclonidine versus 360 degrees with apraclonidine.
Allf BE; Shields MB
Ophthalmic Surg; 1991 Sep; 22(9):539-42. PubMed ID: 1682861
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
